Overview

Melatonin for Migraine Prevention

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The circadian system with its centre in the hypothalamus is involved in migraine pathophysiology. Whether it plays a pivotal role is not clarified. The investigators postulate that a destabilized circadian system may increase migraine attack susceptibility, and that stabilization by supplying melatonin a migraine preventive effect will be achieved. A previous open label study has shown effects that certainly warrant a placebo controlled study.
Phase:
Phase 2
Details
Lead Sponsor:
Nordlandssykehuset HF
Collaborator:
University of Tromso
Treatments:
Melatonin